Picard Medical, Inc. 8K

Picard Medical released a pre‑recorded stockholder presentation ahead of its July 17, 2026 annual meeting highlighting strong recent financial results, product development milestones for its Emperor artificial heart platform, manufacturing initiatives, and the proposals to be voted on by stockholders.

On July 10, 2026, Picard Medical, Inc. (NYSE American: PMI), parent of SynCardia Systems, announced the release of a pre‑recorded annual stockholder presentation ahead of its virtual 2026 Annual Meeting of Stockholders on July 17, 2026, outlining recent business performance, including an 85% year‑over‑year revenue increase and improved gross margin for the first quarter of 2026, ongoing manufacturing optimization initiatives, development progress and regulatory roadmap for its next‑generation Emperor total artificial heart platform, and the matters to be voted on at the meeting such as director elections, amendments to the company’s capital structure, ratification of the independent auditor, and advisory votes on executive compensation.

Filing Facts

CIK

2030617

Ticker

-

Form

8K

Source Type

sec

Accession

0001437749-26-023381

Alert Tier

5